Genomic Health(美国)

Genomic Health

美国GenomicHealthwww.genomichealth.com美国癌症分子诊断市场第二大厂为GenomicHealth约占美国癌症分子诊断市场27.7%，且几乎完全来自乳腺癌市场，它的OncotypeDXR.测试在早期乳腺癌病人中，能预测乳腺癌的续发可能性以及化疗的效果，该公司以产品的差异化战略取得了市场显著的突破。GenomicHealth,alifesciencecompanyfou ndedinAugustof2000andlocatedinRedwoodCity,California,iscommittedtoimprovingthequalityofcancertreatmentdecisionsthroughtheresearch,developmentandcommercializationofgenomic-basedclinicallaboratoryservices.Tothatend,thecompanyconductssophisticatedgenomicresearchtodevelopclinically-validatedmoleculardiagnosticswhichprovideindividualizedinformationonresponsetocertaintypesoftherapy,aswellasthelikelihoodofdiseaserecurrence.Thesediagnostictechnologiesgenerateinformationthathealthcareprovidersandpatientscanuseinmakingtreatmentdecisions.ThepioneeringworkofGenomicHealthinmoleculardiagnosticshasledtotheOncotypeDXBreastCancerAssay,alaboratorytestthatanalyze